Market research
SSKN STRATA Skin Sciences Inc
PINK USD Healthcare
Latest close
As of 10 Sep 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1K
- P/E ratio
- Not available
- Analyst target
- 10.8
- Dividend yield
- Not available
- Beta
- 0.21
Profile
Instrument facts
- Exchange
- PINK
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 1K
- P/E ratio
- Not available
- Analyst target
- 10.8
- Dividend yield
- Not available
- Beta
- 0.21
About
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
Research context
STRATA Skin Sciences Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the SSKN discussion.
5 years, 6 months ago
STRATA Skin Sciences, Inc is currently in a long term downtrend where the price is trading 10.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
STRATA Skin Sciences, Inc's total revenue sank by 24.5% to $7M since the same quarter in the previous year.
Its net income has increased by 99.9% to $-443 since the same quarter in the previous year.
Finally, its free cash flow fell by 254.8% to $-1M since the same quarter in the previous year.
Based on the above factors, STRATA Skin Sciences, Inc gets an overall score of 2/5.